Income Statement
BLUEJAY DIAGNOSTICS, INC.
BJDX
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
- | - | - | 0.25 | - |
|
Cost of Revenue
|
- | - | 0.00 | 0.20 | - |
|
Gross Profit
|
- | - | - | 0.05 | - |
|
Operating Expenses
|
6.95 | 7.17 | 10.31 | 9.37 | 3.23 |
|
Research & Development
|
3.05 | 3.47 | 5.71 | 4.15 | 1.15 |
|
Selling, General & Administrative
|
3.91 | 3.69 | 4.31 | 4.76 | 1.79 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-6.95 | -7.17 | -10.31 | -9.32 | -3.23 |
|
Non-Operating Income
|
0.10 | -0.55 | 0.36 | 0.02 | -0.26 |
|
Interest Income
|
0.10 | 0.15 | 0.16 | - | - |
|
Interest Expense
|
- | 0.81 | - | - | 0.01 |
|
Other Non-Op Income / Expense
|
0.01 | - | 0.19 | - | - |
|
Income Before Tax
|
- | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-6.85 | -7.72 | -9.95 | 9.30 | -3.49 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-6.95 | -7.17 | -10.31 | -9.16 | -3.08 |
|
Earnings Per Share (Basic)
|
-15.25 | -114.19 | -9.08 | -0.46 | - |
|
Diluted EPS
|
-15.25 | -114.19 | - | - | - |
|
Weighted Average Shares
|
0.45 | 0.18 | 1.10 | 20.16 | - |
|
Diluted Weighted Avg Shares
|
0.45 | 0.18 | - | - | - |
|
Comprehensive Income
|
- | - | - | - | - |